Paratek生物制药

PRTK NASDAQ
3.260
-0.110
-3.26%
交易中 14:02 07/23 EDT
开盘
3.390
昨收
3.370
最高
3.500
最低
3.250
成交量
9.41万
成交均量(3M)
29.79万
52周最高
12.30
52周最低
3.130
换手率
0.29%
市值
1.06亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Paratek生物制药 PRTK股票价格,Paratek生物制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Paratek Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics based upon tetracycline chemistry. Its product candidates are the antibacterials omadacycline and sarecycline. Omadacycline is an antibiotic being developed for use as an empiric monotherapy option for patients suffering from serious, community-acquired bacterial infections. Sarecycline is a tetracycline-derived compound designed for use in the treatment of acne and rosacea. Its other product candidates are tetracycline-derived, molecular entities and are designed to utilize the recognized immune-modulation, anti-inflammatory and other beneficial properties of the tetracycline class. These research stage programs include product candidates for multiple sclerosis, spinal muscular atrophy, systemic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel diseases.
展开 >

最近浏览

名称
价格
涨跌幅